TRIAX PHARMACEUTICALS LLC – Trademark Portfolio
Entity Type: 16
TRIAX PHARMACEUTICALS LLC holds 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 5 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include MINOCIN. The owner is based in CRANFORD, NJ.
20 COMMERCE DRIVE
CRANFORD, NJ 07016
Showing of trademarks Trademarks
Trademark Classifications
TRIAX PHARMACEUTICALS LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does TRIAX PHARMACEUTICALS LLC have?
TRIAX PHARMACEUTICALS LLC has 9 U.S. trademarks filed with the USPTO. Of these, 1 registered, 3 abandoned, 4 cancelled.
What trademark classes does TRIAX PHARMACEUTICALS LLC file in?
TRIAX PHARMACEUTICALS LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 3 (Cosmetics & Cleaning). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are TRIAX PHARMACEUTICALS LLC's most well-known trademarks?
TRIAX PHARMACEUTICALS LLC's registered trademark portfolio includes well-known marks such as MINOCIN. These are among 1 currently registered trademark in the portfolio.
What is TRIAX PHARMACEUTICALS LLC's trademark registration success rate?
TRIAX PHARMACEUTICALS LLC has a 13% trademark registration rate, with 1 out of 8 resolved applications resulting in successful registration. Currently, 0 applications are pending review.